Standard BioTools: Outlook Still Murky [Seeking Alpha]
Standard BioTools Inc. (LAB)
Company Research
Source: Seeking Alpha
LAB will receive $350M upfront and up to $75M in earnouts from Illumina for SomaScan, leaving $550M in cash post-transaction. Management projects Adj. EBITDA breakeven in 2026 after divestiture and a 20% workforce reduction, but ongoing operations lack clear growth catalysts. An analysis around Standard BioTools follows in the paragraphs below. ConceptCafe/iStock via Getty Images Shares of life sciences instrument concern Standard BioTools Inc. ( LAB have rallied some 20% since its 3Q25 financial report on November 4, 2025, while it awaits the close of its SomaScan sale in 1H26. The prime reason for the rally More on my IG service Live Chat on The Biotech Forum sees frequent discussion of specific covered call trades. To see what covered call trades I am currently executing along with a model portfolio of attractive biotech stocks, just initiate your free trial into The Biotech Forum by clicking HERE This article was written by Analyst's Disclosure: I/we have no stock
Show less
Read more
Impact Snapshot
Event Time:
LAB
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LAB alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LAB alerts
High impacting Standard BioTools Inc. news events
Weekly update
A roundup of the hottest topics
LAB
News
- Institutional owners may consider drastic measures as Standard BioTools Inc.'s (NASDAQ:LAB) recent US$96m drop adds to long-term losses [Yahoo! Finance]Yahoo! Finance
- Standard BioTools (NASDAQ:LAB) was upgraded by analysts at Zacks Research to a "hold" rating.MarketBeat
- Molecular Instruments and Standard BioTools Announce Collaboration to Bring Amplified Multi-Omic Readouts to Imaging Mass Cytometry [Yahoo! Finance]Yahoo! Finance
- Molecular Instruments and Standard BioTools Announce Collaboration to Bring Amplified Multi-Omic Readouts to Imaging Mass CytometryBusiness Wire
- Standard BioTools (NASDAQ:LAB) had its price target lowered by analysts at TD Cowen from $1.55 to $1.35. They now have a "hold" rating on the stock.MarketBeat
LAB
Earnings
- 8/11/25 - Miss
LAB
Sec Filings
- 12/4/25 - Form 4
- 11/28/25 - Form SCHEDULE
- 11/26/25 - Form 4
- LAB's page on the SEC website